#wegovy
FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option
In a major development for obesity treatment, the US Food and Drug Administration has approved the first oral version of Wegovy, marking a significant shift in how weight-loss medications can be administered. The approval was announced by Danish pharmaceutical giant Novo Nordisk, which described the tablet
FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option
In a major development for obesity treatment, the US Food and Drug Administration has approved the first oral version of Wegovy, marking a significant shift in how weight-loss medications can be administered. The approval was announced by Danish pharmaceutical giant Novo Nordisk, which described the tablet
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
Wegovy Weight-Loss Injection Now Available in India
Novo Nordisk has launched its groundbreaking weight-loss drug, Wegovy, in India. This semaglutide-based injection promises to help individuals tackle obesity and related heart risks, offering a solution to India's growing health concerns. Available as a once-weekly injection, Wegovy works by mimicking the body's natural GLP-1 hormone, which regulates hunger, reduces cravings, and helps control blood sugar. Clinical trials have shown that Wegovy can res
Wegovy Weight-Loss Injection Now Available in India
Novo Nordisk has launched its groundbreaking weight-loss drug, Wegovy, in India. This semaglutide-based injection promises to help individuals tackle obesity and related heart risks, offering a solution to India's growing health concerns. Available as a once-weekly injection, Wegovy works by mimicking the body's natural GLP-1 hormone, which regulates hunger, reduces cravings, and helps control blood sugar. Clinical trials have shown that Wegovy can res
Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026
Under a new cost-cutting proposal by Governor Gavin Newsom, California may soon eliminate Medi-Cal coverage for popular weight loss drugs Ozempic and Wegovy, sparking concern among healthcare advocates and low-income patients. The move, which aims to address a $12 billion state budget deficit, could take effect on January 1, 2026, and would save the state an estimated $85 million in 2025–26 and up to $680 million by 2028–29, according to Newsom's office. Ozempic and
Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026
Under a new cost-cutting proposal by Governor Gavin Newsom, California may soon eliminate Medi-Cal coverage for popular weight loss drugs Ozempic and Wegovy, sparking concern among healthcare advocates and low-income patients. The move, which aims to address a $12 billion state budget deficit, could take effect on January 1, 2026, and would save the state an estimated $85 million in 2025–26 and up to $680 million by 2028–29, according to Newsom's office. Ozempic and









